lebrikizumab
Showing 1 - 24 of 24
Atopic Dermatitis, Eczema Trial (Lebrikizumab, Placebo)
Not yet recruiting
- Atopic Dermatitis
- Eczema
- Lebrikizumab
- Placebo
- (no location specified)
Feb 10, 2023
Dermatitis, Atopic, Eczema Trial in Worldwide (Lebrikizumab, Lebrikizumab-matching Placebo)
Recruiting
- Dermatitis, Atopic
- Eczema
- Lebrikizumab
- Lebrikizumab-matching Placebo
-
Nantes, Loira Atlantico, France
- +1 more
Jun 8, 2022
Healthy Trial in United States (Lebrikizumab)
Recruiting
- Healthy
- Lebrikizumab
-
Daytona Beach, Florida
- +3 more
Jan 17, 2022
Atopic Dermatitis Trial (Lebrikizumab)
Recruiting
- Atopic Dermatitis
- Lebrikizumab
-
Birmingham, Alabama
- +20 more
Jan 17, 2023
Atopic Dermatitis Trial (Lebrikizumab)
Recruiting
- Atopic Dermatitis
- Lebrikizumab
-
Birmingham, Alabama
- +23 more
Jan 17, 2023
Dermatitis, Atopic, Dermatitis, Eczema Trial in Japan (Lebrikizumab, Placebo, Topical Corticosteroid)
Active, not recruiting
- Dermatitis, Atopic
- +4 more
- Lebrikizumab
- +2 more
-
Ainokawa, Ichikawa-shi, Chiba, Japan
- +36 more
Sep 19, 2022
Atopic Dermatitis Trial in United States (Lebrikizumab, Placebo)
Completed
- Atopic Dermatitis
- Lebrikizumab
- Placebo
-
Birmingham, Alabama
- +84 more
Oct 20, 2022
Atopic Dermatitis, Eczema Trial in Worldwide (Lebrikizumab, Placebo, Topical corticosteroid)
Recruiting
- Atopic Dermatitis
- Eczema
- Lebrikizumab
- +2 more
-
Birmingham, Alabama
- +94 more
Jan 17, 2023
Atopic Dermatitis Trial in United States (Lebrikizumab, Placebo)
Completed
- Atopic Dermatitis
- Lebrikizumab
- Placebo
-
Scottsdale, Arizona
- +57 more
Apr 9, 2021
Atopic Dermatitis Trial in Canada, United States (Lebrikizumab, Topical Corticosteroid Creams (Triamcinolone acetonide 0.1% and
Completed
- Atopic Dermatitis
- Lebrikizumab
- Topical Corticosteroid Creams (Triamcinolone acetonide 0.1% and Hydrocortisone 2.5%)
-
Encino, California
- +18 more
Jan 17, 2020
Asthma Trial (Lebrikizumab, Prefilled Syringes)
Withdrawn
- Asthma
- Lebrikizumab
- Prefilled Syringes
- (no location specified)
Apr 23, 2018
Idiopathic Pulmonary Fibrosis Trial in Worldwide (Lebrikizumab, Pirfenidone, Placebo)
Completed
- Idiopathic Pulmonary Fibrosis
- Lebrikizumab
- +2 more
-
Birmingham, Alabama
- +111 more
Aug 22, 2018
Asthma Trial in Worldwide (Lebrikizumab, Placebo, Inhaled corticposteroids (ICS))
Completed
- Asthma
- Lebrikizumab
- +3 more
-
Tucson, Arizona
- +27 more
Sep 4, 2017
COPD Trial in Worldwide (Lebrikizumab, Placebo)
Completed
- Chronic Obstructive Pulmonary Disease
- Lebrikizumab
- Placebo
-
Birmingham, Alabama
- +65 more
Sep 5, 2017
Atopic Dermatitis Trial in Worldwide (Lebrikizumab, Placebo, TCS Cream)
Completed
- Atopic Dermatitis
- Lebrikizumab
- +2 more
-
Los Angeles, California
- +73 more
Sep 28, 2017
Healthy Volunteer Trial in Honolulu (lebrikizumab, )
Completed
- Healthy Volunteer
- lebrikizumab
- placebo
-
Honolulu, Hawaii(unnamed)
Nov 1, 2016
Healthy Volunteer Trial in United States (Lebrikizumab)
Completed
- Healthy Volunteer
- Lebrikizumab
-
Daytona Beach, Florida
- +3 more
Nov 1, 2016
Asthma Trial in Worldwide (Lebrikizumab, Placebo)
Completed
- Asthma
- Lebrikizumab
- Placebo
-
Bakersfield, California
- +70 more
May 19, 2017
Asthma Trial in Australia, United States (lebrikizumab, )
Completed
- Asthma
- lebrikizumab
- placebo
-
Oxford, Alabama
- +63 more
Nov 1, 2016
Asthma Trial in Worldwide (Lebrikizumab, Placebo)
Completed
- Asthma
- Lebrikizumab
- Placebo
-
Pell City, Alabama
- +229 more
May 18, 2017
Asthma Trial in Worldwide (Lebrikizumab, Placebo)
Completed
- Asthma
- Lebrikizumab
- Placebo
-
Birmingham, Alabama
- +231 more
May 18, 2017
Asthma Trial in Worldwide (Lebrikizumab, Placebo, Standard of Care)
Completed
- Asthma
- Lebrikizumab
- +2 more
-
Tucson, Arizona
- +164 more
May 15, 2017
Asthma Trial in Worldwide (lebrikizumab, montelukast [Singulair], )
Completed
- Asthma
- lebrikizumab
- +2 more
-
Birmingham, Alabama
- +112 more
Nov 1, 2016
Asthma Trial in Australia, United States (lebrikizumab, )
Completed
- Asthma
- lebrikizumab
- placebo
-
Pell City, Alabama
- +70 more
Mar 3, 2015